Humira

Humira

M725/0465 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 28.0MB

Downloadable file size: 1.2MB

Price image Pricing

Please login to use the price calculator


Credit: JOHN KAPRIELIAN/SCIENCE PHOTO LIBRARY

Caption: 0.8ml prefilled syringe of Humira (Adalimumab), a biologic medication for the treatment of rheumatoid and psoriatic arthritis, autoimmune diseases. Humira is a human monoclonal antibody which targets excess tumor necrosis factor, a protein capable of destroying cancer cells, in the joint fluid. Overproduction of tumor necrosis factor causes inflammation, swelling, and pain. Humira was approved for use by the FDA in 2003.

Release details: Model release not required. Property release not required.

Keywords: adalimumab, antibody, arthritis treatment, autoimmune, autoimmune diseases, biologic, drug take, healthcare, humira, medical, medical treatment, medicate, medication, medicine, monoclonal antibody, necroses, necrosis, prescribed medication, prescription medications, psoriatic arthritic, syringe, taking, tnf, treatment, tumor, tumor necroses

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.